Dephosphorylation of CDK9 by protein phosphatase 2A and protein phosphatase-I in Tat-activated HIV-I transcription

Retrovirology

Volumn 2, Issue , 2005, Pages

  Ammosova, Tatyana ^a   Washington, Kareem ^a   Debebe, Zufan ^a   Brady, John ^c   Nekhai, Sergei ^a,b  

^a HOWARD UNIVERSITY   (United States)

^b HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 9; ELONGATION FACTOR; ELONGATION FACTOR P TEFB; OKADAIC ACID; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 2A; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; SERINE; THREONINE; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; VIRUS RNA; CDK9 PROTEIN, HUMAN; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE 2;

ANIMAL CELL; ARTICLE; AUTOPHOSPHORYLATION; CELL CULTURE; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME INHIBITION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSACTIVATION; TRANSCRIPTION REGULATION; VIRUS TRANSCRIPTION; ANIMAL; CELL STRAIN COS1; CERCOPITHECUS; GENETIC TRANSCRIPTION; GENETICS; LONG TERMINAL REPEAT; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; CYCLIN-DEPENDENT KINASE 9; GENE PRODUCTS, TAT; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; PHOSPHOPROTEIN PHOSPHATASES; PHOSPHORYLATION; PROTEIN PHOSPHATASE 1; PROTEIN PHOSPHATASE 2; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TRANSCRIPTION, GENETIC;

EID: 27344456057     PISSN: 17424690     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-2-47     Document Type: Article

References (36)

1. Marcello A, Zoppe M, Giacca M: Multiple modes of transcriptional regulation by the HIV-1 Tat transactivator. IUBMB Life 2001, 51:175-181.
2. Liang C, Wainberg MA: The role of Tat in HIV-1 replication: an activator and/or a suppressor? AIDS Rev 2002, 4:41-49.
3. Giacca M: The HIV-1 Tat protein: a multifaceted target for novel therapeutic opportunities. Curr Drug Targets Immune Endocr Metabol Disord 2004, 4:277-285.
4. Brigati C, Giacca M, Noonan DM, Albini A: HIV Tat, its TARgets and the control of viral gene expression. FEMS Microbiol Lett 2003, 220:57-65.
5. Kim YK, Bourgeois CF, Isel C, Churcher MJ, Karn J: Phosphorylation of the RNA polymerase II carboxyl-terminal domain by CDK9 is directly responsible for human immunodeficiency virus type 1 Tat-activated transcriptional elongation. Mol Cell Biol 2002, 22:4622-4637.
6. Zhu Y, Pe'ery T, Peng J, Ramanathan Y, Marshall N, Marshall T, Amendt B, Mathews MB, Price DH: Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro. Genes Dev 1997, 11:2622-2632.
7. Raha T, Cheng SW, Green MR: HIV-1 Tat stimulates transcription complex assembly through recruitment of TBP in the absence of TAFs. PLoS Biol 2005, 3:e44.
8. Jeang KT, Berkhout B, Dropulic B: Effects of integration and replication on transcription of the HIV-1 long terminal repeat. J Biol Chem 1993, 268:24940-24949.
9. Jeang KT, Berkhout B: Kinetics of HIV-1 long terminal repeat trans-activation. Use of intragenic ribozyme to assess rate-limiting steps. J Biol Chem 1992, 267:17891-17899.
10. Kashanchi F, Piras G, Radonovich MF, Duvall JF, Fattaey A, Chiang CM, Roeder RG, Brady JN: Direct interaction of human TFIID with the HIV-1 transactivator tat. Nature 1994, 367:295-299.
11. Herrmann CH, Rice AP: Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactor. J Virol 1995, 69:1612-1620.
12. Yang X, Gold MO, Tang DN, Lewis DE, Aguilar-Cordova E, Rice AP, Herrmann CH: TAK, an HIV Tat-associated kinase, is a member of the cyclin-dependent family of protein kinases and is induced by activation of peripheral blood lymphocytes and differentiation of promonocytic cell lines. Proc Natl Acad Sci U S A 1997, 94:12331-12336.
13. Kiernan RE, Vanhulle C, Schiltz L, Adam E, Xiao H, Maudoux F, Calomme C, Burny A, Nakatani Y, Jeang KT, Benkirane M, Van Lint C: HIV-1 tat transcriptional activity is regulated by acetylation. Embo J 1999, 18:6106-6118.
14. Ott M, Schnolzer M, Garnica J, Fischle W, Emiliani S, Rackwitz HR, Verdin E: Acetylation of the HIV-1 Tat protein by p300 is important for its transcriptional activity. Curr Biol 1999, 9:1489-1492.
15. Deng L, de la Fuente C, Fu P, Wang L, Donnelly R, Wade JD, Lambert P, Li H, Lee CG, Kashanchi F: Acetylation of HIV-1 Tat by CBP/P300 increases transcription of integrated HIV-1 genome and enhances binding to core histones. Virology 2000, 277:278-295.
16. Bieniasz PD, Grdina TA, Bogerd HP, Cullen BR: Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat. Embo J 1998, 17:7056-7065.
17. Garber ME, Wei P, KewalRamani VN, Mayall TP, Herrmann CH, Rice AP, Littman DR, Jones KA: The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes Dev 1998, 12:3512-3527.
18. Garber ME, Mayall TP, Suess EM, Meisenhelder J, Thompson NE, Jones KA: CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 tat-PTEFb complex to TAR RNA. Mol Cell Biol 2000, 20:6958-6969.
19. Zhou M, Nekhai S, Bharucha DC, Kumar A, Ge H, Price DH, Egly JM, Brady JN: TFIIH inhibits CDK9 phosphorylation during human immunodeficiency virus type 1 transcription. J Biol Chem 2001, 276:44633-44640.
20. Bollen M, Beullens M: Signaling by protein phosphatases in the nucleus. Trends Cell Biol 2002, 12:138-145.
21. Ruediger R, Brewis N, Ohst K, Walter G: Increasing the ratio of PP2A core enzyme to holoenzyme inhibits Tat-stimulated HIV-1 transcription and virus production. Virology 1997, 238:432-443.
22. Faulkner NE, Lane BR, Bock PJ, Markovitz DM: Protein phosphatase 2A enhances activation of human immunodeficiency virus type 1 by phorbol myristate acetate. J Virol 2003, 77:2276-2281.
23. Beullens M, Van Eynde A, Stalmans W, Bollen M: The isolation of novel inhibitory polypeptides of protein phosphatase 1 from bovine thymus nuclei. J Biol Chem 1992, 267:16538-16544.
24. Jagiello I, Beullens M, Stalmans W, Bollen M: Subunit structure and regulation of protein phosphatase-1 in rat liver nuclei. J Biol Chem 1995, 270:17257-17263.
25. Bharucha DC, Zhou M, Nekhai S, Brady JN, Shukla RR, Kumar A: A protein phosphatase from human T cells augments tat transactivation of the human immunodeficiency virus type 1 long-terminal repeat. Virology 2002, 296:6-16.
26. Ammosova T, Jerebtsova M, Beullens M, Voloshin Y, Ray PE, Kumar A, Bollen M, Nekhai S: Nuclear protein phosphatase-1 regulates HIV-1 transcription. J Biol Chem 2003, 278:32189-32194.
27. Beullens M, Stalmans W, Bollen M: The biochemical identification and characterization of new species of protein phosphatase 1. Methods Mol Biol 1998, 93:145-155.
28. Li Q, Price JP, Byers SA, Cheng D, Peng J, Price DH: Analysis of the large inactive P-TEFb complex indicates that it contains one 7SK molecule, a dimer of HEXIM1 or HEXIM2, and two PTEFb molecules containing Cdk9 phosphorylated at threonine 186. J Biol Chem 2005.
29. Washington K, Ammosova T, Beullens M, Jerebtsova M, Kumar A, Bollen M, Nekhai S: Protein phosphatase- dephosphorylates the C-terminal domain of RNA polymerase-II. J Biol Chem 2002, 277:40442-40448.
30. Beullens M, Vulsteke V, Van Eynde A, Jagiello I, Stalmans W, Bollen M: The C-terminus of NIPPI (nuclear inhibitor of protein phosphatase-1) contains a novel binding site for protein phosphatase-1 that is controlled by tyrosine phosphorylation and RNA binding. Biochem J 2000, 352 Pt 3:651-658.
31. Kaehlcke K, Dorr A, Hetzer-Egger C, Kiermer V, Henklein P, Schnoelzer M, Loret E, Cole PA, Verdin E, Ott M: Acetylation of Tat defines a cyclin T1-independent step in HIV transactivation. Mol Cell 2003, 12:167-176.
32. Moreno CS, Ramachandran S, Ashby DG, Laycock N, Plattner CA, Chen W, Hahn WC, Pallas DC: Signaling and transcriptional changes critical for transformation of human cells by simian virus 40 small tumor antigen or protein phosphatase 2A B56gamma knockdown. Cancer Res 2004, 64:6978-6988.
33. Chen R, Yang Z, Zhou Q: Phosphorylated positive transcription elongation factor b (P-TEFb) is tagged for inhibition through association with 7SK snRNA. J Biol Chem 2004, 279:4153-4160.
34. Peng J, Zhu Y, Milton JT, Price DH: Identification of multiple cyclin subunits of human P-TEFb. Genes Dev 1998, 12:755-762.
35. Kimpton J, Emerman M: Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene. J Virol 1992, 66:2232-2239.
36. Verhoef K, Bauer M, Meyerhans A, Berkhout B: On the role of the second coding exon of the HIV-1 Tat protein in virus replication and MHC class 1 downregulation. AIDS Res Hum Retroviruses 1998, 14:1553-1559.